Barrington Research Issues Positive Forecast for U.S. Physical Therapy (NYSE:USPH) Stock Price

Key Points

• Barrington Research raised U.S. Physical Therapy’s price target from $90 to $98 and maintained an “outperform” rating, implying 22.67% upside from the reported $79.89 price.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $99.50 from seven analysts.
• The company’s latest quarter showed 8.5% year-over-year revenue growth to $214.06 million, though EPS of $0.75 missed estimates by $0.06.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) had its price target lifted by investment analysts at Barrington Research from $90.00 to $98.00 in a report issued on Monday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Barrington Research's price target points to a potential upside of 22.67% from the company's current price.

A number of other research firms also recently commented on USPH. Citizens Jmp restated a "market outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Citigroup reiterated a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Friday, July 24th. Zacks Research upgraded shares of U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a report on Wednesday, May 27th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and an average price target of $99.50.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $79.89 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.19 and a current ratio of 1.27. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of 469.97, a price-to-earnings-growth ratio of 2.18 and a beta of 1.13. U.S. Physical Therapy has a one year low of $58.19 and a one year high of $93.50. The company has a 50 day moving average price of $70.17 and a 200 day moving average price of $74.15.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.06). The company had revenue of $214.06 million for the quarter, compared to analysts' expectations of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.81 earnings per share. Sell-side analysts anticipate that U.S. Physical Therapy will post 2.98 EPS for the current year.

Insider Transactions at U.S. Physical Therapy

In other news, Director Peter Francis Minan acquired 492 shares of the business's stock in a transaction on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the acquisition, the director directly owned 2,923 shares of the company's stock, valued at $184,558.22. This represents a 20.24% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Hantz Financial Services Inc. increased its holdings in U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company's stock worth $29,000 after purchasing an additional 132 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at approximately $30,000. Advisory Services Network LLC purchased a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at approximately $39,000. iSAM Funds UK Ltd acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth approximately $52,000. Finally, Parallel Advisors LLC increased its stake in shares of U.S. Physical Therapy by 75.2% in the first quarter. Parallel Advisors LLC now owns 785 shares of the company's stock worth $59,000 after buying an additional 337 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source